We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
The Therapeutic Goods Administration (TGA) has issued a $2,664 infringement notice to a NSW-based individual for allegedly advertising nicotine vaping products for sale via their website.
Despite being informed about the operation of the law for these prescription medicines, the individual allegedly continued to advertise nicotine vaping products to the public.
Nicotine vaping products are prescription only medicines that may only be obtained with a valid prescription from an Australian registered doctor.
Prescription only medicines are prohibited from being advertised to the public unless the advertisement meets the conditions of the Therapeutic Goods (Restricted and Prohibited Representations - Nicotine) Permission (No. 2) 2021.
The rules around the import, manufacture, advertising and supply of nicotine vaping products balance the need to prevent adolescents and young adults from taking-up nicotine vaping (and potentially cigarette smoking) while enabling current smokers to access these products for smoking cessation with appropriate medical support.
If you suspect non-compliance in relation to therapeutic goods, you can report illegal or questionable practices online to the TGA.
The TGA encourages the reporting of suspected non-compliant advertising.
Media contact:
- Email: news@health.gov.au
- Phone: 02 6289 7400